After a stunning Q1 earnings report and raised full-year guidance, the question is whether the valuation has run ahead of ...

What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 2.4% in the afternoon session after the ...

The recent Lilly stock bounce has created a seasonal selling opportunity despite pricing headwinds and a rich valuation.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Eli Lilly is set to post earnings Thursday morning, with the stock seen potentially sinking to its lowest level in months following the report.

TheFly reported on May 5 that Barclays increased its valuation outlook for LLY, raising the price target to $1,400 from ...

Eli Lilly and Company ( NYSE:LLY ) is about to trade ex-dividend in the next 3 days. The ex-dividend date occurs ...

Eli Lilly and Company’s LLY stock has risen 16.2% since it announced robust first-quarter 2026 results on April 30. The ...

In this photo illustration, a Eli Lilly logo seen displayed on a smartphone. Eli Lilly’s stock (NYSE: LLY) has recently surged 27% over the past month, reaching a current price of $1,022. This rally ...

Eli Lilly and Company’s LLY stock has been consistently trading above its 50-day and 200-day simple moving averages (SMAs) since early October. The 50-day moving average is a short-term indicator, ...

Eli Lilly stock (NYSE: LLY) is up 10% this month, a rise driven by strong clinical trial progress. This includes the announcement of positive Phase 3 results in October 2025 for its oral GLP-1 drug, ...

Eli Lilly (LLY) stock dropped 3% on Foundayo liver concerns. Analysts say the decline is overdone and recommend buying the ...